FACULTAD DE CIENCIAS BIOMÉDICAS Y DE LA SALUD
Facultad
The Bristol-Myers Squibb Children's Hospital
Nuevo Brunswick, Estados UnidosPublicaciones en colaboración con investigadores/as de The Bristol-Myers Squibb Children's Hospital (3)
2020
-
Impact of alemtuzumab on health-related quality of life over 6 years in CARE-MS II trial extension patients with relapsing-remitting multiple sclerosis
Multiple Sclerosis Journal, Vol. 26, Núm. 8, pp. 955-963
2013
-
Dasatinib plus capecitabine for advanced breast cancer: Safety and efficacy in phase I study CA180004
Clinical Cancer Research, Vol. 19, Núm. 7, pp. 1884-1893
2012
-
Phase i safety, pharmacokinetic and pharmacodynamic trial of BMS-599626 (AC480), an oral pan-HER receptor tyrosine kinase inhibitor, in patients with advanced solid tumors
Annals of Oncology, Vol. 23, Núm. 2, pp. 463-471